Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report)’s share price traded down 2.8% during mid-day trading on Wednesday . The stock traded as low as $8.16 and last traded at $8.26. 334,673 shares changed hands during mid-day trading, a decline of 1% from the average session volume of 337,931 shares. The stock had previously closed at $8.50.
Silverback Therapeutics Trading Down 2.8 %
The firm has a market cap of $297.84 million, a price-to-earnings ratio of -3.41 and a beta of 0.60. The firm’s fifty day moving average price is $8.80 and its 200-day moving average price is $6.35.
About Silverback Therapeutics
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Featured Stories
- Five stocks we like better than Silverback Therapeutics
- Why Are Stock Sectors Important to Successful Investing?
- High-Yield Texas Instruments Could Hit New Highs Soon
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Comparing and Trading High PE Ratio Stocks
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg?v=20230303072534&h=45&w=95&zc=2){kind=logo}